ArticleScientific reports2025
Machine learning identifies KRT8 dysregulation and endothelial remodeling in Moyamoya disease.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Molecular and multimodal biomarkers in Moyamoya disease: from pathogenic mechanisms to clinical translation.European journal of medical research · 2026Review
- HGSNAT alleviates oxygen-glucose deprivation- induced endothelial injury by suppressing ER stress: implications for Moyamoya disease.Frontiers in molecular neuroscience · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Moyamoya disease (MMD) is a rare occlusive cerebrovascular disease, and its pathological mechanism remains unclear at present. The abnormal vascular remodeling may be involved in vascular endothelial cells. In this study, RNA seq was performed on the superficial temporal arteries of 10 patients with MMD. Integrated analysis was conducted by combining validation set with training set. Key genes were identified through differential analysis and WGCNA. The functions of potential biomarkers were explored by methods such as correlation analysis, KEGG analysis, PPI network, and tube formation experiments. Integrated analysis of three cohorts (43 MMD vs. 26 controls) identified 19 shared DEGs, including upregulated KRT8/KRT18 and downregulated NT5C2 (P < 0.001). Enrichment revealed dysregulation in circadian rhythm, calcium signaling, and metabolic pathways (P < 0.05). Immune infiltration showed elevated pro-inflammatory cells (neutrophils, M1 macrophages) and reduced Tregs/NK cells (P < 0.05). Machine learning (SVM-RFE, Boruta, LASSO) prioritized KRT8 as diagnostic markers (AUC > 0.96). KRT8 overexpression enhanced angiogenesis in HBMECs (1.5-fold tube formation, P < 0.01). This omics approach delineates MMD's molecular interplay between inflammation, metabolism, and vascular remodeling. KRT8 may promote vascular remodeling in MMD by regulating the tube-forming ability of endothelial cells. This could be a highlight of therapeutic targets for MMD and shed light on the mechanism research of MMD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.